Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B-cell receptors (BCRs) and T-cell receptors (TCRs) specific for the NIP (4-hydroxy-3-iodo-5-nitrophenylacetic acid) hapten are specialized immunological tools used primarily in experimental research to study the adaptive immune system (Reth et al., Eur J Immunol, 1978). NIP is a synthetic hapten that, when conjugated to carrier proteins, serves as a model antigen to investigate processes such as affinity maturation, somatic hypermutation, and clonal selection in B and T lymphocytes (Bothwell et al., Cell, 1981). These receptors are often expressed in transgenic mouse models, such as the B1-8 strain, allowing researchers to track specific immune cell populations and their responses to controlled antigenic stimuli (Sonoda et al., Immunity, 1997). Because NIP is a synthetic compound not found in nature, these receptors do not play a role in human disease and are not targets for therapeutic drug development. Instead, they provide a high-precision system for fundamental immunological discovery and the validation of vaccine strategies in laboratory settings (Allen et al., Science, 2007). The interaction between the NIP hapten and these receptors is characterized by high specificity, which has been extensively mapped at the molecular level to understand how the immune system distinguishes between closely related chemical structures. This system remains a cornerstone of molecular immunology for studying the kinetics of the primary and secondary immune responses.
Not applicable as this is an experimental research model system rather than a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B-cell receptors and T-cell receptors specific for the 4-hydroxy-3-iodo-5-nitrophenylacetic acid (NIP) hapten (NIP-specific BCR/TCR).